pentoxifylline has been researched along with Colitis in 7 studies
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to identify the effect of pentoxifylline on trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats." | 7.85 | Pentoxifylline attenuates mucosal damage in an experimental model of rat colitis by modulating tissue biomarkers of inflammation, oxidative stress, and fibrosis. ( Arhan, M; Ekinci, Ö; Erdal, H; G Dumlu, Ş; Gül Utku, Ö; Ibiş, M; Karatay, E; Önal, İK; Yilmaz Demirtaş, C, 2017) |
| "The effect of acute pentoxifylline treatment in an experimental model of colitis was assessed using the trinitrobenzene sulphonic acid (TNBS)-induced rat model of colitis." | 7.69 | Effect of acute pentoxifylline treatment in an experimental model of colitis. ( Davey, K; Peterson, TC, 1997) |
| "Pentoxifylline and M-1 treatment significantly attenuated colon damage and inflammation in TNBS-colitis (P<0." | 5.37 | The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. ( Peterson, MR; Peterson, TC; Raoul, JM, 2011) |
| "Colitis was induced by rectal administration of ethanol and trinitrobenzene sulfonic acid in rats." | 5.31 | Lisofylline and lysophospholipids ameliorate experimental colitis in rats. ( Dignass, AU; Gerken, G; Rath, H; Sturm, A; Sudermann, T; Zeeh, J, 2002) |
| "Colitis was induced by the feeding of 3% DSS for three cycles." | 5.30 | Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. ( Cooper, HS; Meyer, C; Meyer, CJ; Murthy, NS; Murthy, S; Yoshitake, H, 1999) |
| "This study was designed to identify the effect of pentoxifylline on trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats." | 3.85 | Pentoxifylline attenuates mucosal damage in an experimental model of rat colitis by modulating tissue biomarkers of inflammation, oxidative stress, and fibrosis. ( Arhan, M; Ekinci, Ö; Erdal, H; G Dumlu, Ş; Gül Utku, Ö; Ibiş, M; Karatay, E; Önal, İK; Yilmaz Demirtaş, C, 2017) |
| " Here we assessed the ability of PDE inhibitors to modulate colitis by exposing mice to 4% (w/v) dextran sulfate sodium (DSS) drinking water for 5 days with or without rolipram, an inhibitor of PDE type 4, or the nonselective PDE inhibitor, pentoxifylline (both at 5 mg/kg, i." | 3.70 | Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. ( Diaz-Granados, N; Howe, K; Lu, J; McKay, DM, 2000) |
| "The effect of acute pentoxifylline treatment in an experimental model of colitis was assessed using the trinitrobenzene sulphonic acid (TNBS)-induced rat model of colitis." | 3.69 | Effect of acute pentoxifylline treatment in an experimental model of colitis. ( Davey, K; Peterson, TC, 1997) |
| "Pentoxifylline and M-1 treatment significantly attenuated colon damage and inflammation in TNBS-colitis (P<0." | 1.37 | The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. ( Peterson, MR; Peterson, TC; Raoul, JM, 2011) |
| "Colitis was induced by rectal administration of ethanol and trinitrobenzene sulfonic acid in rats." | 1.31 | Lisofylline and lysophospholipids ameliorate experimental colitis in rats. ( Dignass, AU; Gerken, G; Rath, H; Sturm, A; Sudermann, T; Zeeh, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karatay, E | 1 |
| Gül Utku, Ö | 1 |
| Erdal, H | 1 |
| Arhan, M | 1 |
| Önal, İK | 1 |
| Ibiş, M | 1 |
| Ekinci, Ö | 1 |
| Yilmaz Demirtaş, C | 1 |
| G Dumlu, Ş | 1 |
| Peterson, TC | 2 |
| Peterson, MR | 1 |
| Raoul, JM | 1 |
| Sturm, A | 1 |
| Zeeh, J | 1 |
| Sudermann, T | 1 |
| Rath, H | 1 |
| Gerken, G | 1 |
| Dignass, AU | 1 |
| Bauditz, J | 1 |
| Rückert, Y | 1 |
| Raedler, A | 1 |
| Nikolaus, S | 1 |
| Lochs, H | 1 |
| Schreiber, S | 1 |
| Davey, K | 1 |
| Murthy, S | 1 |
| Cooper, HS | 1 |
| Yoshitake, H | 1 |
| Meyer, C | 1 |
| Meyer, CJ | 1 |
| Murthy, NS | 1 |
| Diaz-Granados, N | 1 |
| Howe, K | 1 |
| Lu, J | 1 |
| McKay, DM | 1 |
7 other studies available for pentoxifylline and Colitis
| Article | Year |
|---|---|
Pentoxifylline attenuates mucosal damage in an experimental model of rat colitis by modulating tissue biomarkers of inflammation, oxidative stress, and fibrosis.
Topics: Animals; Biomarkers; Colitis; Disease Models, Animal; Female; Fibrosis; Inflammation; Intestinal Muc | 2017 |
The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis.
Topics: Animals; Colitis; Collagen Type I; Colon; Disease Models, Animal; Female; Fibrosis; Inflammation; In | 2011 |
Lisofylline and lysophospholipids ameliorate experimental colitis in rats.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Ethanol; Lysopho | 2002 |
Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease.
Topics: Adult; Colitis; Crohn Disease; Female; Humans; Male; Pentoxifylline; Tumor Necrosis Factor-alpha | 1995 |
Effect of acute pentoxifylline treatment in an experimental model of colitis.
Topics: Animals; Colitis; Collagen; Colon; Disease Models, Animal; Male; Pentoxifylline; Phosphodiesterase I | 1997 |
Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis.
Topics: Animals; Antibodies, Monoclonal; Colitis; Dextran Sulfate; Female; Immunoglobulin G; Mice; Pentoxify | 1999 |
Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.
Topics: Animals; Biological Transport; Colitis; Colon; Cytokines; Dextran Sulfate; Epithelium; Intestinal Mu | 2000 |